Evidence map›Paper›PMID 37152653›Full record

ReviewFrontiers in bioengineering and biotechnology2023

Functional insights to the development of bioactive material for combating bacterial infections.

Duoyang Fan, Xiaohui Liu, Yueming Ren, Shuaige Bai, Yanbing Li, Ziheng Luo, Jie Dong, Fei Chen, Wenbin Zeng

Abstract readReview
In one paragraph

Review in Frontiers in bioengineering and biotechnology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Review
  3. Membrane-Focused Strategies AgainstAntibiotics (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Duoyang FanXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Xiaohui LiuXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Yueming RenXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Shuaige BaiXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Yanbing LiXiangya Hospital, Central South University, Changsha, China.
Ziheng LuoXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Jie DongXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Fei ChenXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
Wenbin ZengXiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The emergence of antibiotic-resistant "superbugs" poses a serious threat to human health. Nanomaterials and cationic polymers have shown unprecedented advantages as effective antimicrobial therapies due to their flexibility and ability to interact with biological macromolecules. They can incorporate a variety of antimicrobial substances, achieving multifunctional effects without easily developing drug resistance. Herein, this article discusses recent advances in cationic polymers and nano-antibacterial materials, including material options, fabrication techniques, structural characteristics, and activity performance, with a focus on their fundamental active elements.

Indexed as

antibacterialcationic polymersmultidrug-resistant bacterial biofilmnanomaterialstheranostics

Identifiers

PMID37152653
PMCPMC10160456

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.